Human neural progenitor cells, originally isolated from prenatal donor tissue at 17 weeks of development, were cultured as neurospheres and transplanted to the vitreous cavity of dystrophic Royal College of Surgeons rats with, or without, cyclosporin A immunosuppression. Donor cells were either unlabeled or prelabeled, the latter utilizing incubation with BrdU or adenoviral modification to express green fluorescent protein. Recipients of various ages were examined at 1, 2, and 4 weeks postgrafting. Transplanted human neural progenitor cells survived in the host vitreous for at least 4 weeks and maintained expression of green fluorescent protein for at least 2 weeks. After 2 weeks in vivo, grafted cells differentiated morphologically, coincident with expression of the neuronal marker MAP, indicating mature neuronal differentiation. The extensive intraretinal migration previously shown using rat progenitor cells in the Royal College of Surgeons rat model was not seen in this experiment, suggesting that high levels of neuronal migration may depend at least in part upon species-specific molecular cues. Human neural progenitor cells represent a renewable source of multipotent human cells capable of in vivo neuronal development and a potential means of delivering therapeutic factors intraocularly. Human neural progenitor cells therefore provide a useful tool for studies of neural development and differentiation in the dystrophic eye.
INTRODUCTION
cytes, NPCs migrated into the brain and appeared to specifically differentiate into oligodendrocytes (39) . In an-Neural stem and progenitor cells comprise a class of other report, NPCs injected into the bloodstream of immature cells giving rise, over the course of developpartially irradiated mice engrafted and gave rise to cells ment, to all the cells of the nervous system. These cells of the hematopoietic lineage (3) . therefore include the antecedents of all neurons in the Previous neural transplantation studies directed at the brain, spinal cord, and retina. Advances in cell culture retina have often relied on embryonic or immature tissue technology have made possible the isolation and in vitro as a source of cells with sufficient plasticity to yield propagation of neural progenitor cells (NPCs) from roviable engraftment (8, 9, 15, 16) . Transplanted to the eye, embryonic retinae differentiate from a primitive pseudo-dents (3, 28, 35) and humans (4, 11, 32) . These cells retain stratified neuroepithelium into a laminar structure conmany immature characteristics, including the expression taining recognizable retinal cell types. There is, howof nestin and the ability to divide, yet differentiate into ever, a notable tendency to form rosettes and these grafts neurons, astrocytes, and oligodendrocytes under certain appear to remain cytoarchitecturally segregated from the conditions. host retina. As elsewhere in the CNS (1, 14) , the graft-In a number of animal models, transplanted neural host interface is frequently delineated by a glial scar, progenitor cells have demonstrated an ability to survive, although neurites can, to some extent, cross between migrate, and differentiate along lineages appropriate to graft and host (41) . The factors underlying the apparent the context with which they are presented. For instance, reluctance of embryonic tissue to effectively intercalate when transplanted to the cerebral ventricle of immature with the host neuroretinal parenchyma are not under-Shiverer mice with a primary defect in oligodendro-224 MIZUMOTO ET AL. stood. Even when dissociated and transplanted to the Donor Cell Labeling brain as a reaggregate, embryonic retinae develop as a A portion of the hNPCs was prelabeled with either nidus of grafted tissue (22) rather than migrating into GFP or BrdU. In the case of GFP, hNPCs were incuthe parenchyma in the manner of astrocytes (21). bated with adenoviral vector (6 × 10 6 colony-forming Neural progenitor cells present a potential means of units) encoding GFP with a CMV promoter at 37°C in circumventing the limitations encountered when using 5% CO 2 for 22 h. Cells were then collected by centrifuembryonic tissue for retinal transplantation. Recent work gation and resuspended in fresh culture medium. Alterhas shown that adult hippocampal progenitor cells (AHnatively, hNPCs were pulsed with BrdU (1 µM) for 2 PCs) can migrate into the retina of normal neonatal rats days prior to transplantation. after intravitreal injection (33) . Moreover, we found that these same cells are capable of extensive morphological Histology of In Vitro Cell Cultures integration and neuronal differentiation within the injured retina of adult Fischer rats, as well as the dystro-Spheres were removed from culture flasks, fixed with phic retina of the adult Royal College of Surgeons 4% paraformaldehyde, cryoprotected, and sectioned at 6 (RCS) rat, when injected intravitreally (40). This is in µm on a cryostat. To examine the capacity of progenitor marked contrast to the results obtained in uninjured Ficells to differentiate, additional spheres were cultured in scher and nondystrophic RCS rats, where only limited DMEM/F12 + 10% FBS in 24-well plates. After 14 migration and integration was detected.
days, cultures were fixed with 4% paraformaldehyde Other studies have shown that hNPCs do have the and processed for immunohistochemistry. Sections were capacity to survive, migrate, and integrate within the rat blocked in 1% BSA with 0.2% Triton X, incubated with central nervous system (12, 32) . Moreover, a previous primary antibodies to green fluorescent protein (GFP, 1: study using an hNT neuronal cell line grafted to the ro-500; Clontech), microtubule associated protein (MAPs, dent retina demonstrated that survival and migration of 1:200; Sigma), neural stem cell marker (nestin, 1:1; Dehuman neuronal cells could be achieved in the rodent velopmental Studies Hybridoma Bank, U. of Iowa), glial retina (20). Here we show that human neural progenitor fibrillar acidic protein (GFAP, 1:50; Sigma), or neuroficells can be prelabeled in vitro, survive, and be identilament 200 (NF200, 1:1000; Sigma) for 90 min at room fied after transplantation and undergo neuronal differentemperature, then incubated with a species-specific IgG tiation within the rat eye. Interestingly, human neural secondary antibody conjugated to Cy3 for an additional progenitor cells (hNPCs) do not exhibit the apparent tro-60 min. pism for the dystrophic rat retina shown by allogeneic AHPCs.
Recipient Animals
Four-week-old animals (n = 10) received intravitreal MATERIALS AND METHODS injections of unlabeled hNPCs, were immunosuppressed Donor Cells and Cell Culture with cyclosporin A, and examined at 1 week (n = 4), 2 weeks (n = 4), and 4 weeks (n = 2) posttransplantation. Human neural progenitor cells were obtained as pro-One-week-old animals (n = 20) also received injections prietary cells from Clonetics, Inc., with approval from of unlabeled hNPCs into the vitreous, without immunothe Schepens Eye Research Institute Committee on Resuppression, and were examined at 1 week (n = 8), 2 sponsible Conduct in Research. Originally isolated from weeks (n = 6), and 4 weeks (n = 6) posttransplantation. whole-brain homogenate at 17 weeks of development, Four-week-old (n = 10) and 8-week-old (n = 10) anithe cells were shipped frozen and first cultured in our mals received injections of BrdU-prelabeled hNPCs into laboratory as primary passage "neurospheres" (Fig. 1A) .
the vitreous without immunosuppression and were ex-Thawed cells were cultured in DMEM/F12 suppleamined at 1 week (n = 4, 4-week-old group; n = 4, 8mented with L-glutamine, N2 Supplement (Life Tech- week-old group), 2 weeks (n = 4, 4-week-old group; n = nologies), b-FGF, and EGF (both factors: human recom-4, 8-week-old group), and 4 weeks (n = 2, 4-week-old binant, used at 20 ng/ml, Promega). The cells formed group; n = 2, 8-week-old group) posttransplantation. spheres that enlarged to diameters of 1-3 mm when Six-week-old (n = 6) animals received injections of grown in uncoated flasks ( Fig. 1 ). Cells were passaged GFP-expressing hNPCs into the vitreous together with by dissociation in trypsin/EDTA, after which new immunosuppression and were examined at 1 week (n = spheres formed within 2-3 days. Spheres used for trans-2), 2 weeks (n = 2), and 4 weeks (n = 2) posttransplantaplantation were of passage 3-4, cultured for approximately 3-4 weeks prior to grafting. tion. Immunosuppression for hematoxylin and eosin, or for immunohistochemistry. Of the 56 recipient animals in this study, 16 (29%)
Sections processed for BrdU immunodetection were were given oral cyclosporin A at approximately 2-3 mg/ first incubated in 50% formamide at 56°C for 2 h, rinsed day (1 mg/10 ml) for 3 days prior to transplantation and in SSC twice at room temperature, incubated in 2 N HCl throughout the remainder of the experiment. This conat 37°C for 30 min, and washed in 0.1 M borate buffer centration was chosen based upon the established regifor 10 min at room temperature. After rinses, sections men for achieving therapeutic titers in adult rats.
were blocked in TBS containing 0.1% Triton X and 3% goat serum for 30 min at room temperature, followed by Transplantation incubation in anti-BrdU (1:400) at 4°C for 24 h. Intraocular injections of hNPCs were made with the Sections from animals that had received unlabeled recipients under general anesthesia (ketamine/xylazine, hNPCs were incubated with anti-human tau or pig IgM-IP) supplemented with topical anesthesia to the eye (pro-FITC (Accurate Chemical) to detect grafted cells. Priparacaine) and were performed under direct observation mary antibodies against GFP (1:500; Clontech), MAPs using a surgical microscope (Möller) focused through (1:200; Sigma), NF200 (1:1000; Sigma), or human tau the dilated pupil of the recipient eye (topical tropicamide (1:200; Oncogene Research) were reacted for 60 min 1%). The cells were introduced by a beveled glass miwith species-specific IgG secondary conjugated to Cy3 cropipette (outside diameter = 1 mm) connected via PE (1:150; Jackson Immunochemicals). tubing to a 50-µl Hamilton microsyringe. The small diameter and oblique entry of the pipette resulted in a RESULTS self-sealing wound. Several hNPCs spheres (a total of In Vitro Cell Cultures and Histology approximately 50,000-100,000 cells) in 1-2 µl of DMEM/F12 media were injected per graft.
The gene for jellyfish green fluorescent protein was introduced into hNPCs using an adenoviral construct.
Tissue Preparation and Histology
Modified neurospheres maintained expression of the GFP marker gene for at least 4 weeks ( Fig. 2A, B ). At 1, 2, and 4 weeks posttransplantation, eyes were These same cells also expressed nestin ( Fig. 2C ) but not removed under terminal anesthesia and fixed by immer-MAPs ( Fig. 2D ) or NF200 (data not shown), consistent sion in 4% paraformaldehyde, then cryoprotected with with a proto-neural phenotype. After culturing in 24-20% sucrose and frozen in embedding media. Eyes were well plates in the presence of 10% FBS for 14 days, sectioned at 8 µm on a cryostat, resulting in approximately 500 sections per eye. Sections were processed GFP+ cells migrated away from the spheres and began to differentiate (Fig. 3A ). Some of these differentiating Unlabeled hNPCs transplanted into nonimmunosupcells expressed MAPs (Fig. 3B ), while others expressed pressed RCS rats (1-week-old hosts, n = 20) survive in GFAP ( Fig. 3C ) and a few expressed NF200 (data not the vitreous in 8 of 8 eyes (100%), 2 of 6 eyes (33%), shown). These in vitro results indicate that virally inand 0 of 6 eyes (0%) at 1, 2, and 4 weeks posttransplanfected hNPCs maintain their undifferentiated status tation, respectively. while retaining the capability of differentiating along Grafted cells were visualized by anti-human tau imboth neuronal and glial lineages. munocytochemistry (Fig. 4) , which could be detected in animals at time points examined in immunosuppressed recipients. We were unable to reliably label grafted hu-Fate of Transplanted hNPCs (see Table 1 ) man cells with the pig IgM-FITC antibody, which should Unmodified Donor Cells. Unlabeled hNPCs transreact to specific carbohydrate moieties on the surface of planted into immunosuppressed RCS rats (4-week-old discordant cells (e.g., human). No grafted cells were hosts, n = 10) were found within the vitreous, or at the found within the host retina. vitreo-retinal interface, in 4 of 4 eyes (100%), 4 of 4
Donor Cells Labeled With BrdU. BrdU prelabeled eyes (100%), and 1 of 2 eyes (50%) at 1, 2, and 4 weeks posttransplantation, respectively. hNPCs were transplanted into nonimmunosuppressed RCS rats of two different ages: 4 weeks (n = 10) and 8 identified in the vitreous at 1 week posttransplantation ( Fig. 5 ). Using hematoxylin and eosin staining, intravi-weeks (n = 10).
In the 4-week host group, BrdU-positive cells were treal cells were identified in 4 of 4 eyes (100%) at both 1-and 2-week time points and in 2 of 2 eyes (100%) found in the vitreous, or at the vitreo-retinal interface, in 3 of 4 eyes (75%) at both 1-and 2-week time points at 4 weeks postgrafting. Although cells again tended to accumulate at the vitreo-retinal interface, once posttransplantation and in 2 of 2 eyes (100%) at 4 weeks posttransplantation.
again there was no indication of migration into the host retina. In the 8-week host group, BrdU-positive cells were Donor Cells Modified to Express GFP. Spheres of genitor cell (AHPCs). Like AHPCs, hNPCs survive for hNPCs previously modified to express GFP (Fig. 1B) at least 4 weeks following intravitreal transplantation were injected into the vitreous of 6-week-old dystrophic into actively degenerating RCS rats, maintain expression RCS rats (n = 6). Grafted hNPC spheres were found at, of a GFP reporter gene during at least part of this time or near, the vitreal surface of the retina in all eyes at 1, in vivo, and, ultimately, exhibit evidence for neuronal 2, and 4 weeks postgrafting; however, migration of differentiation in the form of MAPs and h-tau expres-GFP-positive cells into the host retina was not present sion. Multiple strategies were employed to label grafted ( Fig. 6) . At 1 and 2 weeks postgrafting, injected cells cells; however, none proved to be ideal. We were neversurvived and maintained GFP expression; however, at theless able to follow the fate of at least a proportion of the 4-week time point hNPCs were more evident using the cells following transplantation. anti-GFP immunoreactivity and Cy3 illumination than Even though human NPCs showed excellent survival with direct GFP fluorescence under FITC (Fig. 6C, F , in many cases, these grafts did not demonstrate the I). Grafted cells showed high levels of MAPs expression widespread intraretinal migration and morphological inat 2 weeks postgrafting and neurite-like processes could tegration seen in the normal neonatal rat (33) and, to an be seen at high magnification (Fig. 7) . even greater extent, in the mature dystrophic rat (40) following intravitreal injection of rat AHPCs. Therefore,
Expression of Neuronal and Glial Lineage Markers
despite the general similarities of these cell types in Grafted hNPCs differentiated into cells that morphovitro, the in vivo results differ markedly. Studying the logically resembled mature neurons. The expression of variables responsible for this incongruity might reveal neuronal and glial lineage markers was not, however, the determinants crucial for successful integration of a detected at high levels in all grafts. Grafted cells did cell into the retina. There are a number of factors to express human tau (Fig. 4) , as well as MAPs (Fig. 7) , consider in this regard. after transplantation to immunosuppressed recipients;
Evidence from a number of laboratories, including however, levels of expression varied considerably. We our own, has indicated that an underlying degenerative did not detect expression of astrocytic (GFAP) or oligoprocess enhances, rather than mitigates, the integration dendrocytic (GalC) markers by grafted cells (data not of grafted neural precursors. It is primarily for that reashown), although GFAP expression could be seen in culson that we chose the RCS rat as a recipient. As mentured cells exposed to serum (Fig. 3) .
tioned above, we found that only in the setting of retinal DISCUSSION injury (either genetic or traumatic in origin) would grafted AHPCs migrate into the mature neuroretina in This intraocular transplantation study of human neusubstantial numbers. Similarly, in preliminary studies ral progenitor cells (hNPCs) reiterates some, but not all, of the findings we obtained previously using a rat pro-with the hNPC cell line used here, no integration was seen in normal rats (data not shown), prompting us to properties of progenitor cells (5, 13, 23, 26, 29) it seems likely that the majority of immature cells in the fetus are examine the RCS rat as a recipient. There are many complex issues to consider when evaluating experiments moving rapidly towards site-specific terminal differentiation, whereas the few progenitor cells remaining in such as these, including immunogeneic disparity, ongoing degeneration, and immunological privilege of the adulthood might be biased toward long-term maintenance of their relatively undifferentiated state. Further-donor tissue as well as the graft site. These complexities preclude firm conclusions regarding the behavior of more, AHPCs were clonally derived from the hippocampal formation, whereas hNPCs were obtained from hNPCs following transplantation. Ongoing experiments are aimed at understanding the mechanisms underlying whole-brain homogenates without clonal considerations. Taken together, these observations lend credence to the migration of grafted neural precursors into the mature CNS.
theoretical argument that all neural progenitor cells are not entirely equivalent. The cells used in this study were originally harvested from a prenatal source, whereas the rat cells used pre-The most dramatic difference between the present experiment and the previous (40) is that of donor species. viously were derived from mature animals. While it is not presently clear whether donor age influences the Species-related differences could modify transplantation necessary for neural guidance, synapse formation, proliferation, and differentiation is complex and not completely understood (30) . The genes for such cues will not necessarily be entirely conserved across species (2,6), thereby posing a potential barrier to the integration of neural xenografts. Interestingly, there is evidence that functional cross-species connectivity is possible in at least some cases (19) . Moreover, substantial neuronal integration is achievable using a similar cell type to that presented here. Recent work has shown that hNPCs grafted to the brain of rats can survive and develop into mature neurons (32) . However, in this paradigm, grafted cells were placed into the brain parenchyma, rather than the cerebral ventricles, the latter being more analogous to the vitreous cavity. It is worth noting, however, that experiments in our laboratory in which grafted hNPC were placed into the subretinal space (more analogous to the CNS parenchyma) have also failed to show any evidence of neuronal migration or integration (data not shown). Additional species-related considerations include the inherent phylogenetic capacity of a given species towards regeneration, as well as the substantial size disparity between donor and host cells often seen with xenografts. function. We submit that NPCs, such as those described here, may represent a preferable source of cells for this neuroprotective strategy. NPCs are easily cultured, can outcome in a number of ways, foremost among these being immunological disparity. Although hNPCs did sur-be expanded in vitro, and can be modified to express transgenes. Importantly, these cells are readily trans-vive long enough that evidence of intraretinal migration might be expected, it is possible that the cells were ei-plantable, can stably integrate into many neuronal environments (5, 27, 31) , and can continue to express foreign ther inhibited by immunological factors or destroyed upon entering the host retina. Against this argument is proteins after transplantation (11) . The retina is an excellent candidate site for the delivery of therapeutic factors the lack of an evident retinal or vitreal mononuclear infiltrate, although the process could be subtle. Also by these means, as the transplantation of cells to this region is relatively noninvasive vis-à-vis intracerebral against it is the absence of intraretinal migration in the cyclosporin A treatment group, in which immunological grafting. Furthermore, a variety of factors appear to prolong the survival of dystrophic photoreceptors (10, 36) , factors should pose less of a hindrance. In addition, immunological disparity might be expected to play a less to cite but one of the many potential applications of this strategy. Much work is needed, however, before consid-prominent role when transplanting to an immunoprivileged site such as the vitreous cavity (17, 18, 37, 38) . In ering the use of such grafts in the clinical setting. While there are a number of models demonstrating this regard it should, however, be noted that the question of whether immune privilege is fully maintained in the morphological integration of transplanted glial cells into the CNS, those showing integration of neurons are few. setting of neural degeneration has not been directly investigated (25) .
We are currently carrying out additional experiments aimed at determining the mechanisms underlying the MHC class I gene products have been suggested as putative guidance molecules during neural development ability of grafted progenitor cells to migrate into host tissue. At this time, the factors controlling neuronal inte- (7) , and this could potentially contribute to species-associated differences in neural integration. In general, it can gration remain a matter of speculation. It does, however, seem likely that the increasing availability of neural pro-be appreciated that the constellation of molecular cues neuronal differentiation of human neural progenitor cells genitor cells from a variety of species, the ability to inafter transplantation in the adult rat brain. J. Neurosci. troduce transgenes and the many gene knockout animals 19(14) 
